<DOC>
	<DOCNO>NCT00635973</DOCNO>
	<brief_summary>A trial ass patient treat Iressa previous clinical trial may benefit continued treatment Iressa .</brief_summary>
	<brief_title>Open-Label Extension Other SZ1839 ( Iressa ) Trials</brief_title>
	<detailed_description />
	<mesh_term>Gefitinib</mesh_term>
	<criteria>Received treatment previous Iressa clinical trial Provided Informed Consent participate trial 30 day less since complete previous Iressa trial . Radiotherapy complete 14 day start treatment trial Incomplete heal prior surgery Withdrawal previous Iressa trial due unacceptable toxicity major organ</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>Iressa</keyword>
	<keyword>Gefitinib</keyword>
	<keyword>Cancer</keyword>
	<keyword>Patients diagnose cancer previously receive Iressa Iressa clinical trial</keyword>
</DOC>